Twelve militants of Islamic Jihad Mujahideen Jamaat grouping detained in KaliningradSociety & Culture April 27, 2:14
Russian Prosecutor General’s Office finds another 3 NGOs to be undesirableRussian Politics & Diplomacy April 26, 21:42
Moscow ‘seriously concerned’ about Turkish airstrikes in Iraq, SyriaRussian Politics & Diplomacy April 26, 20:55
North Korea ‘neither fears war nor wants to avoid it,’ says country’s UN missionWorld April 26, 20:37
Russia’s Emergencies Ministry to continue helping Serbia in mine clearance in 2017Military & Defense April 26, 20:20
Putin says Russia, China maintain relations at 'unprecedentedly high level'Russian Politics & Diplomacy April 26, 20:02
Polls shows number of happy Russians at record-breaking historic highSociety & Culture April 26, 19:27
IS recruiting Taliban fighters in Afghanistan — Russia’s General StaffMilitary & Defense April 26, 18:49
Coffin with presumed remains of 19th century Russian general dug up in TurkeySociety & Culture April 26, 18:26
MOSCOW, June 3. /TASS/. India’s Glenmark Pharmaceuticals Ltd is exploring an opportunity of localizing ready pharmaceutical drugs production in Russia, general director of Glenmark’s division in Russia Glenmark Impex Elena Astakhova said.
"We have such ideas and we are considering such an opportunity in principle. However, no final decision has been made yet," Astakhova said. She did not clarify the timeline and basic parameters of projects.
The company has no local production in Russia for the time being. The annual turnover of Glenmark in Russia is estimated at 2 bln rubles ($37.5 mln). Glenmark owns 14 ready drugs and substances factories in four countries and six research centers.